Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets

Bibliographic Details
Main Authors: Adviti Naik, Joe Yeong, Julie Decock
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1075329/full
_version_ 1817975989953626112
author Adviti Naik
Joe Yeong
Joe Yeong
Julie Decock
Julie Decock
author_facet Adviti Naik
Joe Yeong
Joe Yeong
Julie Decock
Julie Decock
author_sort Adviti Naik
collection DOAJ
first_indexed 2024-04-13T21:57:38Z
format Article
id doaj.art-aaa1527012c0448f842cb46b41b304b8
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-13T21:57:38Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-aaa1527012c0448f842cb46b41b304b82022-12-22T02:28:13ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-11-011210.3389/fonc.2022.10753291075329Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targetsAdviti Naik0Joe Yeong1Joe Yeong2Julie Decock3Julie Decock4Translational Cancer and Immunity Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, QatarInstitute of Molecular and Cell Biology (ASTAR), Singapore, SingaporeDivision of pathology, Singapore General Hospital, Singapore, SingaporeTranslational Cancer and Immunity Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, QatarCollege of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatarhttps://www.frontiersin.org/articles/10.3389/fonc.2022.1075329/fullcancer testis antigencancer biologycancer biomarkercancer therapyimmunotherapy
spellingShingle Adviti Naik
Joe Yeong
Joe Yeong
Julie Decock
Julie Decock
Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
Frontiers in Oncology
cancer testis antigen
cancer biology
cancer biomarker
cancer therapy
immunotherapy
title Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
title_full Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
title_fullStr Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
title_full_unstemmed Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
title_short Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
title_sort editorial cancer testis antigens in cancer recent developments as cancer biomarkers and therapeutic targets
topic cancer testis antigen
cancer biology
cancer biomarker
cancer therapy
immunotherapy
url https://www.frontiersin.org/articles/10.3389/fonc.2022.1075329/full
work_keys_str_mv AT advitinaik editorialcancertestisantigensincancerrecentdevelopmentsascancerbiomarkersandtherapeutictargets
AT joeyeong editorialcancertestisantigensincancerrecentdevelopmentsascancerbiomarkersandtherapeutictargets
AT joeyeong editorialcancertestisantigensincancerrecentdevelopmentsascancerbiomarkersandtherapeutictargets
AT juliedecock editorialcancertestisantigensincancerrecentdevelopmentsascancerbiomarkersandtherapeutictargets
AT juliedecock editorialcancertestisantigensincancerrecentdevelopmentsascancerbiomarkersandtherapeutictargets